Investors flock to $PBIO as its Patent PCT Platform goes
Investors flock to $PBIO as its Patent PCT Platform goes mainstream!
http://bit.ly/1ZwJzao
The information provided above came to you from Uptick Newswire (herein referred to as “us”, “we” or “the website”) is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. All information that we provide is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Furthermore, investing in such securities involves substantial risk of loss and investors should seek advice from financial professionals before investing.
Uptick Newswire provides social media outreach and Investor Relations services for Micro-Cap companies. These are paid services. We may from time to time hold shares of companies featured as payment for services rendered. It is understood that Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that the investor’s entire investment may be lost or impaired due to the speculative nature of the companies listed.
Uptick Newswire makes no recommendation that the securities of the companies listed should be purchased, sold or held by individuals or entities that learn of the listed companies through Uptick Newswire representatives or upticknewswire.com. Any suggestions made by Uptick Newswire staff regarding companies featured on upticknewswire.com is solely that “a suggestion” nothing more. It is our expectation that investors will do their own due diligence.
We recommend that readers use the information found within as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. Uptick Newswire is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Mobix Labs Secures AI Drone Contract Mobix Labs, Inc. (NASDAQ: MOBX), a leading provider in advanced connectivity and sensing solutions, has embarked on an exciting journey with a new contract for its Mobix Labs Wireless division, RaGE Systems. They are set to develop cutting-edge drone-based, AI-powered inspection technology specifically for the U.S. rail industry. This...
Continue Reading
Groundbreaking NIH Grant for Lactiga's Antibody Research Lactiga US, Inc., a pioneering biotechnology firm, has secured an important award from the National Institutes of Health (NIH) to enhance the development of its first-in-class secretory IgA (sIgA) antibody targeting inflammatory bowel disease (IBD). Understanding the Power of Breastmilk-Derived Antibodies This...
Continue Reading
Market Growth Overview of Intelligent Electronic Devices The Intelligent Electronic Devices (IED) market is on an impressive trajectory, expected to reach USD 33.49 Billion, increasing significantly from its valuation of USD 14.35 Billion in the near future. This growth reflects a compound annual growth rate (CAGR) of 11.18% between now and 2032. The exciting advancements...
Continue Reading
Exploring Undervalued Energy Stocks for Portfolio Growth As market conditions fluctuate, the energy sector presents intriguing opportunities for investors seeking to enhance their portfolios. With numerous stocks labeled as oversold, there is potential for significant gains. Seeking out undervalued stocks could be a wise strategy, especially those showing a relative...
Continue Reading
Pixi Beauty Introduces Three New Blush Shades Pixi Beauty has recently expanded its popular On-the-Glow Blush collection by adding three exciting new shades: Mauve, Cassis, and Chantilly. These versatile colors are designed to streamline beauty routines with a multi-use balm that enhances your natural beauty effortlessly. The Shift Toward Natural Beauty As the beauty...
Continue Reading